|
|
Article: ESI Lederle Introduces Acyclovir 200 mg Capsules
- Article from:
- PR Newswire
- Article date:
- April 24, 1997
CopyrightCOPYRIGHT 1997 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
PHILADELPHIA, April 24 /PRNewswire/ -- ESI Lederle, a division of Wyeth- Ayerst Laboratories, announced today the availability of Acyclovir 200 mg Capsules. Cleared for marketing by the FDA, ESI Lederle Acyclovir is a generic version of the branded antiviral drug Zovirax(R), marketed by Glaxo Wellcome.
Acyclovir, the second new product to be launched by ESI Lederle during 1997 joins the growing line of oral and injectable products from ESI Lederle.
Acyclovir is a widely used antiviral drug indicated for acute treatment of herpes zoster (shingles) and chickenpox (varicella) and for the treatment of initial episodes and management of recurrent ...